Utility of 18F-Fluoro-Deoxyglucose EmisiOn Tomography/Computed and Sentinel Node Biopsy for Axillary Staging in Primary Breast Cancer. Roffo PET/CT 1 Trial

被引：0
|
作者：
Noblia, C. M.
Cresta Morgado, C. E.
Azar, M. E.
Bruno, G.
Gonzalez, C.
Parma, P.
Gonzalez, E. G.
Armanasco, E.
Montoya, D.
Ipina, J. M.
Zarlenga, C.
Gorostidi, S.
机构：
[1] CABA, Inst Oncol Angel H Roffo, Buenos Aires, DF, Argentina
[2] CABA, Fdn Ctr Diagnost Nucl, Buenos Aires, DF, Argentina
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/0008-5472.SABCS10-P1-01-28
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-01-28
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Combining Diffusion-Weighted Imaging and T2-Weighted Imaging to Delineate Tumorous Tissue in Peritoneal Carcinomatosis: A Comparative Study with 18F-Fluoro-Deoxyglucose Positron Emission Tomography with Computed Tomography (FDG PET/CT)
    Wu, Qing
    Xu, Xiufang
    MEDICAL SCIENCE MONITOR, 2022, 28
  • [32] Role of fluorine-18-labeled 2-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography in the evaluation of axillary lymph node involvement in operable breast cancer in comparison with sentinel lymph node biopsy
    Challa, Vasu Reddy
    Srivastava, Anurag
    Dhar, Anita
    Parshad, Rajinder
    Bal, Chandrasekhar
    Gona, Rama Mohan Reddy
    Kumar, Rakesh
    Gupta, Siddhartha Datta
    Sharma, Punit
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2013, 28 (03): : 138 - 143
  • [33] Evaluation of 18-F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography ( PET/CT) as a staging and monitoring tool for dogs with stage-2 splenic hemangiosarcoma - A pilot study
    Borgatti, Antonella
    Winter, Amber L.
    Stuebner, Kathleen
    Scott, Ruth
    Ober, Christopher P.
    Anderson, Kari L.
    Feeney, Daniel A.
    Vallera, Daniel A.
    Koopmeiners, Joseph S.
    Modiano, Jaime F.
    Froelich, Jerry
    PLOS ONE, 2017, 12 (02):
  • [34] [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients
    Poulsen, Mads H.
    Bouchelouche, Kirsten
    Hoilund-Carlsen, Poul F.
    Petersen, Henrik
    Gerke, Oke
    Steffansen, Signe Inglev
    Marcussen, Niels
    Svolgaard, Niels
    Vach, Werner
    Geertsen, Ulla
    Walter, Steen
    BJU INTERNATIONAL, 2012, 110 (11) : 1666 - 1671
  • [35] Preoperative staging of clinically node-negative esophageal cancer by the combination of 18F-fluorodeoxyglucose positron emission tomography and computed tomography (FDG–PET/CT)
    Masahiko Yano
    Masaaki Motoori
    Koji Tanaka
    Kentaro Kishi
    Yoshiyuki Fujiwara
    Tatsushi Shingai
    Kunihito Gotoh
    Hidenori Takahashi
    Shingo Noura
    Terumasa Yamada
    Masayuki Ohue
    Hiroaki Ohigashi
    Osamu Ishikawa
    Esophagus, 2012, 9 : 210 - 216
  • [36] Utility of [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in the initial staging and response assessment of locally advanced breast cancer patients receiving neoadjuvant chemotherapy
    Hulikal N.
    Gajjala S.R.
    Kalawat T.C.
    Kottu R.
    Yadagiri L.A.
    Indian Journal of Surgical Oncology, 2015, 6 (4) : 330 - 336
  • [37] A prospective study evaluating 18F-Fluorodeoxyglucose (18FDG) positron emission tomography (PET) in the assessment of axillary nodal spread in women undergoing sentinel lymph node biopsy (SLNB) for breast cancer
    Pritchard, K. I.
    Julian, J.
    McCready, D.
    Holloway, C.
    Gulenchyn, K.
    Hodgson, N.
    Lovrics, P.
    Down, N.
    George, R.
    Levine, M. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [38] Evaluating the utility of fluorine-18 fluorodeoxyglucose (18F-FDG)-positron emission tomography (PET)/ computed tomography (CT) scan in cancer of unknown primary.
    Sivakumaran, Tharani
    Cardin, Anthony
    Callahan, Jason
    Wong, Hui-Li
    Tothill, Richard
    Hicks, Rodney
    Mileshkin, Linda R.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [39] Dual time point 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer
    Yamagishi, Yoji
    Koiwai, Tomomi
    Yamasaki, Tamio
    Einama, Takahiro
    Fukumura, Makiko
    Hiratsuka, Miyuki
    Kono, Takako
    Hayashi, Katsumi
    Ishida, Jiro
    Ueno, Hideki
    Tsuda, Hitoshi
    BMC CANCER, 2019, 19 (01)
  • [40] Dual time point 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer
    Yoji YAMAGISHI
    Tomomi KOIWAI
    Tamio YAMASAKI
    Takahiro EINAMA
    Makiko FUKUMURA
    Miyuki HIRATSUKA
    Takako KONO
    Katsumi HAYASHI
    Jiro ISHIDA
    Hideki UENO
    Hitoshi TSUDA
    BMC Cancer, 19
12345